Major histocompatibility complex class I downregulation induced by equine herpesvirus type 1 pUL56 is through dynamin-dependent endocytosis

Journal of Virology

Volumn 88, Issue 21, 2014, Pages 12802-12815

  Huang, Teng ^a   Lehmann, Maik J ^b   Said, Abdelrahman ^a,c   Ma, Guanggang ^a   Osterrieder, Nikolaus ^a  

^a FREIE UNIVERSITÄT BERLIN   (Germany)

^b HUMBOLDT UNIVERSITY   (Germany)

^c NATIONAL RESEARCH CENTRE   (Egypt)

Author keywords

[No Author keywords available]

Indexed keywords

CAVEOLIN 1; CD63 ANTIGEN; CELL SURFACE MARKER; CLATHRIN; DYNAMIN; MEMBRANE COFACTOR PROTEIN; PROTEIN TYROSINE KINASE; UBIQUITIN PROTEIN LIGASE; HLA ANTIGEN CLASS 1; VIRUS PROTEIN;

ARTICLE; CAVEOLA; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL SURFACE; CONTROLLED STUDY; DOWN REGULATION; ENDOCYTOSIS; EQUIDAE; GENE CONTROL; HERPES SIMPLEX VIRUS 1; IMMUNOFLUORESCENCE; IMMUNOMODULATION; LYSOSOME; MAJOR HISTOCOMPATIBILITY COMPLEX; NONHUMAN; OPEN READING FRAME; SIGNAL TRANSDUCTION; UBIQUITINATION; VIRUS ENTRY; WESTERN BLOTTING; ANIMAL; CELL LINE; EQUID HERPESVIRUS 1; FIBROBLAST; HORSE; HOST PATHOGEN INTERACTION; HUMAN; IMMUNE EVASION; IMMUNOLOGY; METABOLISM; VIROLOGY;

ANIMALS; CELL LINE; DOWN-REGULATION; DYNAMINS; ENDOCYTOSIS; FIBROBLASTS; HERPESVIRUS 1, EQUID; HISTOCOMPATIBILITY ANTIGENS CLASS I; HORSES; HOST-PATHOGEN INTERACTIONS; HUMANS; IMMUNE EVASION; VIRAL PROTEINS;

EID: 84907980707     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.02079-14     Document Type: Article

References (73)

1. Wong P, Pamer EG. 2003. CD8 T cell responses to infectious pathogens. Annu.Rev.Immunol.21:29-70.http://dx.doi.org/10.1146/annurev.immunol. 21.120601.141114.
2. Peaper DR, Cresswell P. 2008. Regulation of MHC class I assembly and peptide binding. Annu. Rev. Cell Dev. Biol. 24:343-368. http://dx.doi.org /10.1146/annurev.cellbio.24.110707.175347.
3. Fruh K, Gruhler A, Krishna RM, Schoenhals GJ. 1999. A comparison of viral immune escape strategies targeting the MHC class I assembly pathway. Immunol. Rev. 168:157-166. http://dx.doi.org/10.1111/j.1600-065X.1999.tb01290.x.
4. Lilley BN, Ploegh HL. 2005. Viral modulation of antigen presentation: manipulation of cellular targets in the ER and beyond. Immunol. Rev. 207:126-144. http://dx.doi.org/10.1111/j.0105-2896.2005.00318.x.
5. Burgert HG, Kvist S. 1985. An adenovirus type 2 glycoprotein blocks cell surface expression of human histocompatibility class I antigens. Cell 41: 987-997. http://dx.doi.org/10.1016/S0092-8674(85)80079-9.
6. Fruh K, Ahn K, Djaballah H, Sempe P, van Endert PM, Tampe R, Peterson PA, Yang Y. 1995. A viral inhibitor of peptide transporters for antigen presentation. Nature 375:415-418. http://dx.doi.org/10.1038 /375415a0.
7. Hill A, Jugovic P, York I, Russ G, Bennink J, Yewdell J, Ploegh H, Johnson D. 1995. Herpes simplex virus turns off the TAP to evade host immunity. Nature 375:411-415. http://dx.doi.org/10.1038/375411a0.
8. Koppers-Lalic D, Reits EA, Ressing ME, Lipinska AD, Abele R, Koch J, Marcondes Rezende M, Admiraal P, van Leeuwen D, Bienkowska-Szewczyk K, Mettenleiter TC, Rijsewijk FA, Tampe R, Neefjes J, Wiertz EJ. 2005. Varicelloviruses avoid T cell recognition by UL49.5-mediated inactivation of the transporter associated with antigen processing. Proc. Natl. Acad. Sci. U. S. A. 102:5144-5149. http://dx.doi.org/10.1073/pnas.0501463102.
9. Koppers-Lalic D, Verweij MC, Lipinska AD, Wang Y, Quinten E, Reits EA, Koch J, Loch S, Marcondes Rezende M, Daus F, Bienkowska-Szewczyk K, Osterrieder N, Mettenleiter TC, Heemskerk MH, Tampe R, Neefjes JJ, Chowdhury SI, Ressing ME, Rijsewijk FA, Wiertz EJ. 2008 Varicellovirus UL 49.5 proteins differentially affect the function of the transporter associated with antigen processing, TAP. PLoS Pathog. 4: e1000080. http://dx.doi.org/10.1371/journal.ppat.1000080.
10. Ma G, Azab W, Osterrieder N. 2013. Equine herpesviruses type 1 (EHV-1) and 4 (EHV-4)-masters of co-evolution and a constant threat to equids and beyond. Vet. Microbiol. 167:123-134. http://dx.doi.org/10.1016/j.vetmic.2013.06.018.
11. Kydd JH, Wattrang E, Hannant D. 2003. Pre-infection frequencies of equine herpesvirus-1 specific, cytotoxic T lymphocytes correlate with protection against abortion following experimental infection of pregnant mares. Vet. Immunol. Immunopathol. 96:207-217. http://dx.doi.org/10.1016/j.vetimm.2003.08.004.
12. Rappocciolo G, Birch J, Ellis SA. 2003. Down-regulation of MHC class I expression by equine herpesvirus-1. J. Gen. Virol. 84:293-300. http://dx.doi.org/10.1099/vir.0.18612-0.
13. Ma G, Feineis S, Osterrieder N, Van de Walle GR. 2012. Identification and characterization of equine herpesvirus type 1 pUL56 and its role in virus-induced downregulation of major histocompatibility complex class I. J. Virol. 86:3554-3563. http://dx.doi.org/10.1128/JVI.06994-11.
14. Said A, Azab W, Damiani A, Osterrieder N. 2012. Equine herpesvirus type 4 UL56 and UL49.5 proteins downregulate cell surface major histocompatibility complex class I expression independently of each other. J. Virol. 86:8059-8071. http://dx.doi.org/10.1128/JVI.00891-12.
15. Goodman LB, Loregian A, Perkins GA, Nugent J, Buckles EL, Mercorelli B, Kydd JH, Palu G, Smith KC, Osterrieder N, Davis-Poynter N. 2007 A point mutation in a herpesvirus polymerase determines neuropathogenicity. PLoS Pathog. 3: e160. http://dx.doi.org/10.1371/journal.ppat.0030160.
16. Tischer BK, von Einem J, Kaufer B, Osterrieder N. 2006. Two-step red-mediated recombination for versatile high-efficiency markerlessDNA manipulation in Escherichia coli. Biotechniques 40:191-197. http://dx.doi.org/10.2144/000112096.
17. O' Callaghan DJ, Colle CF, III, Flowers CC, Smith RH, Benoit JN, Bigger CA. 1994. Identification and initial characterization of the IR6 protein of equine herpesvirus 1. J. Virol. 68:5351-5364.
18. von Kleist L, Stahlschmidt W, Bulut H, Gromova K, Puchkov D, Robertson MJ, MacGregor KA, Tomilin N, Pechstein A, Chau N, Chircop M, Sakoff J, von Kries JP, Saenger W, Krausslich HG, Shupliakov O, Robinson PJ, McCluskey A, Haucke V. 2011. Role of the clathrin terminal domain in regulating coated pit dynamics revealed by small molecule inhibition. Cell 146:471-484. http://dx.doi.org/10.1016/j.cell.2011.06.025.
19. Coscoy L, Ganem D. 2000. Kaposi' s sarcoma-associated herpesvirus encodes two proteins that block cell surface display ofMHCclass I chains by enhancing their endocytosis. Proc. Natl. Acad. Sci. U. S. A. 97:8051-8056. http://dx.doi.org/10.1073/pnas.140129797.
20. Cao H, Thompson HM, Krueger EW, McNiven MA. 2000. Disruption of Golgi structure and function in mammalian cells expressing a mutant dynamin. J. Cell Sci. 113:1993-2002.
21. Benmerah A, Lamaze C, Begue B, Schmid SL, Dautry-Varsat A, Cerf-Bensussan N. 1998. AP-2/Eps15 interaction is required for receptormediated endocytosis. J. Cell Biol. 140:1055-1062. http://dx.doi.org/10.1083/jcb.140.5.1055.
22. Stroh T, Erben U, Kuhl AA, Zeitz M, Siegmund B. 2010. Combined pulse electroporation-a novel strategy for highly efficient transfection of human and mouse cells. PLoS One 5: e9488. http://dx.doi.org/10.1371 /journal.pone.0009488.
23. Luzio JP, Pryor PR, Bright NA. 2007. Lysosomes: fusion and function. Nat. Rev. Mol. Cell Biol. 8:622-632. http://dx.doi.org/10.1038/nrm2217.
24. Fredericksen BL, Wei BL, Yao J, Luo T, Garcia JV. 2002. Inhibition of endosomal/lysosomal degradation increases the infectivity of human immunodeficiency virus. J. Virol. 76:11440-11446. http://dx.doi.org/10.1128/JVI.76.22.11440-11446.2002.
25. Dutta D, Donaldson JG. 2012. Search for inhibitors of endocytosis: intended specificity and unintended consequences. Cell Logist. 2:203-208. http://dx.doi.org/10.4161/cl.23967.
26. Drose S, Altendorf K. 1997. Bafilomycins and concanamycins as inhibitors of V-ATPases and P-ATPases. J. Exp. Biol. 200:1-8.
27. Doherty GJ, McMahon HT. 2009. Mechanisms of endocytosis. Annu. Rev. Biochem. 78:857-902. http://dx.doi.org/10.1146/annurev.biochem.78.081307.110540.
28. Macia E, Ehrlich M, Massol R, Boucrot E, Brunner C, Kirchhausen T. 2006 Dynasore, a cell-permeable inhibitor of dynamin. Dev. Cell 10:839-850 http://dx.doi.org/10.1016/j.devcel.2006.04.002.
29. Wang LH, Rothberg KG, Anderson RG. 1993. Mis-assembly of clathrin lattices on endosomes reveals a regulatory switch for coated pit formation. J. Cell Biol. 123:1107-1117. http://dx.doi.org/10.1083/jcb.123.5.1107.
30. Benmerah A, Bayrou M, Cerf-Bensussan N, Dautry-Varsat A. 1999. Inhibition of clathrin-coated pit assembly by an Eps15 mutant. J. Cell Sci. 112:1303-1311.
31. Nabi IR, Le PU. 2003. Caveolae/raft-dependent endocytosis. J. Cell Biol. 161:673-677. http://dx.doi.org/10.1083/jcb.200302028.
32. Schnitzer JE, Oh P, Pinney E, Allard J. 1994. Filipin-sensitive caveolaemediated transport in endothelium: reduced transcytosis, scavenger endocytosis, and capillary permeability of select macromolecules. J. Cell Biol. 127:1217-1232. http://dx.doi.org/10.1083/jcb.127.5.1217.
33. Chen Y, Wang S, Lu X, Zhang H, Fu Y, Luo Y. 2011. Cholesterol sequestration by nystatin enhances the uptake and activity of endostatin in endothelium via regulating distinct endocytic pathways. Blood 117:6392-6403 http://dx.doi.org/10.1182/blood-2010-12-322867.
34. Mundy DI, Li WP, Luby-Phelps K, Anderson RG. 2012. Caveolin targeting to late endosome/lysosomal membranes is induced by perturbations of lysosomal pH and cholesterol content. Mol. Biol. Cell 23:864-880 http://dx.doi.org/10.1091/mbc.E11-07-0598.
35. Vercauteren D, Vandenbroucke RE, Jones AT, Rejman J, Demeester J, De Smedt SC, Sanders NN, Braeckmans K. 2010. The use of inhibitors to study endocytic pathways of gene carriers: optimization and pitfalls. Mol. Ther. 18:561-569. http://dx.doi.org/10.1038/mt.2009.281.
36. Orlichenko L, Huang B, Krueger E, McNiven MA. 2006. Epithelial growth factor-induced phosphorylation of caveolin 1 at tyrosine 14 stimulates caveolae formation in epithelial cells. J. Biol. Chem. 281:4570-4579 http://dx.doi.org/10.1074/jbc.M512088200.
37. Shatz M, Lustig G, Reich R, Liscovitch M. 2010. Caveolin-1 mutants P132L and Y14F are dominant negative regulators of invasion, migration and aggregation in H1299 lung cancer cells. Exp. Cell Res. 316:1748-1762. http://dx.doi.org/10.1016/j.yexcr.2010.02.006.
38. Pelkmans L, Kartenbeck J, Helenius A. 2001. Caveolar endocytosis of simian virus 40 reveals a new two-step vesicular-transport pathway to the ER. Nat. Cell Biol. 3:473-483. http://dx.doi.org/10.1038/35074539.
39. Duncan LM, Piper S, Dodd RB, Saville MK, Sanderson CM, Luzio JP, Lehner PJ. 2006. Lysine-63-linked ubiquitination is required for endolysosomal degradation of class I molecules. EMBO J. 25:1635-1645. http://dx.doi.org/10.1038/sj.emboj.7601056.
40. Ushijima Y, Luo C, Kamakura M, Goshima F, Kimura H, Nishiyama Y. 2010 Herpes simplex virus UL56 interacts with and regulates the Nedd4-family ubiquitin ligase Itch. Virol. J. 7:179. http://dx.doi.org/10.1186/1743-422X-7-179.
41. Yang Y, Kitagaki J, Dai RM, Tsai YC, Lorick KL, Ludwig RL, Pierre SA, Jensen JP, Davydov IV, Oberoi P, Li CC, Kenten JH, Beutler JA, Vousden KH, Weissman AM. 2007. Inhibitors of ubiquitin-activating enzyme (E1), a new class of potential cancer therapeutics. Cancer Res. 67:9472-9481. http://dx.doi.org/10.1158/0008-5472.CAN-07-0568.
42. Liszewski MK, Post TW, Atkinson JP. 1991. Membrane cofactor protein (MCP or CD46): newest member of the regulators of complement activation gene cluster. Annu. Rev. Immunol. 9:431-455. http://dx.doi.org/10.1146/annurev.iy.09.040191.002243.
43. Deckert M, Kubar J, Bernard A. 1992. CD58 and CD59 molecules exhibit potentializing effects in T cell adhesion and activation. J. Immunol. 148: 672-677.
44. Pfistershammer K, Majdic O, Stockl J, Zlabinger G, Kirchberger S, Steinberger P, Knapp W. 2004. CD63 as an activation-linked T cell costimulatory element. J. Immunol. 173:6000-6008. http://dx.doi.org/10.4049/jimmunol.173.10.6000.
45. Krammer PH. 2000. CD95' s deadly mission in the immune system. Nature 407:789-795. http://dx.doi.org/10.1038/35037728.
46. Hansen TH, Bouvier M. 2009.MHCclass I antigen presentation: learning from viral evasion strategies. Nat. Rev. Immunol. 9:503-513. http://dx.doi.org/10.1038/nri2575.
47. Mercer J, Schelhaas M, Helenius A. 2010. Virus entry by endocytosis. Annu. Rev. Biochem. 79:803-833. http://dx.doi.org/10.1146/annurev-biochem-060208-104626.
48. Blagoveshchenskaya AD, Thomas L, Feliciangeli SF, Hung CH, Thomas G. 2002. HIV-1 Nef downregulates MHC-I by a PACS-1-and PI3Kregulated ARF6 endocytic pathway. Cell 111:853-866. http://dx.doi.org /10.1016/S0092-8674(02)01162-5.
49. Ahn K, Meyer TH, Uebel S, Sempe P, Djaballah H, Yang Y, Peterson PA, Fruh K, Tampe R. 1996. Molecular mechanism and species specificity of TAP inhibition by herpes simplex virus ICP47. EMBO J. 15:3247-3255.
50. Tomazin R, Hill AB, Jugovic P, York I, van Endert P, Ploegh HL, Andrews DW, Johnson DC. 1996. Stable binding of the herpes simplex virus ICP47 protein to the peptide binding site of TAP.EMBOJ. 15:3256-3266.
51. Mayor S, Pagano RE. 2007. Pathways of clathrin-independent endocytosis. Nat. Rev. Mol. Cell Biol. 8:603-612. http://dx.doi.org/10.1038/nrm2216.
52. Le Roy C, Wrana JL. 2005. Clathrin-and non-clathrin-mediated endocytic regulation of cell signalling. Nat. Rev. Mol. Cell Biol. 6:112-126. http: //dx.doi.org/10.1038/nrm1571.
53. Liu P, Rudick M, Anderson RG. 2002. Multiple functions of caveolin-1. J. Biol. Chem. 277:41295-41298. http://dx.doi.org/10.1074/jbc.R200020200.
54. Nomura R, Fujimoto T. 1999. Tyrosine-phosphorylated caveolin-1: immunolocalization and molecular characterization. Mol. Biol. Cell 10:975-986 http://dx.doi.org/10.1091/mbc.10.4.975.
55. Qie L, Marcellino D, Herold BC. 1999. Herpes simplex virus entry is associated with tyrosine phosphorylation of cellular proteins. Virology 256:220-227. http://dx.doi.org/10.1006/viro.1999.9673.
56. Damm EM, Pelkmans L, Kartenbeck J, Mezzacasa A, Kurzchalia T, Helenius A. 2005. Clathrin-and caveolin-1-independent endocytosis: entry of simian virus 40 into cells devoid of caveolae. J. Cell Biol. 168:477-488 http://dx.doi.org/10.1083/jcb.200407113.
57. Mulherkar N, Raaben M, de la Torre JC, Whelan SP, Chandran K. 2011. The Ebola virus glycoprotein mediates entry via a non-classical dynamindependent macropinocytic pathway. Virology 419:72-83. http://dx.doi.org/10.1016/j.virol.2011.08.009.
58. Azab W, Lehmann MJ, Osterrieder N. 2013. Glycoprotein H and alpha4beta1 integrins determine the entry pathway of alphaherpesviruses. J. Virol. 87:5937-5948. http://dx.doi.org/10.1128/JVI.03522-12.
59. Hinshaw JE, Schmid SL. 1995. Dynamin self-assembles into rings suggesting a mechanism for coated vesicle budding. Nature 374:190-192. http://dx.doi.org/10.1038/374190a0.
60. Marks B, Stowell MH, Vallis Y, Mills IG, Gibson A, Hopkins CR, McMahon HT. 2001. GTPase activity of dynamin and resulting confor-mation change are essential for endocytosis. Nature 410:231-235. http: //dx.doi.org/10.1038/35065645.
61. Strous GJ, Govers R. 1999. The ubiquitin-proteasome system and endocytosis. J. Cell Sci. 112:1417-1423.
62. Hicke L. 2001. A new ticket for entry into budding vesicles-ubiquitin. Cell 106:527-530. http://dx.doi.org/10.1016/S0092-8674(01)00485-8.
63. Pickart CM, Fushman D. 2004. Polyubiquitin chains: polymeric protein signals. Curr. Opin. Chem. Biol. 8:610-616. http://dx.doi.org/10.1016/j.cbpa.2004.09.009.
64. Means RE, Lang SM, Jung JU. 2007. The Kaposi' s sarcoma-associated herpesvirus K5 E3 ubiquitin ligase modulates targets by multiple molecular mechanisms. J. Virol. 81:6573-6583. http://dx.doi.org/10.1128/JVI.02751-06.
65. Ushijima Y, Koshizuka T, Goshima F, Kimura H, Nishiyama Y. 2008. Herpes simplex virus type 2 UL56 interacts with the ubiquitin ligase Nedd4 and increases its ubiquitination. J. Virol. 82:5220-5233. http://dx.doi.org/10.1128/JVI.02515-07.
66. Riley-Vargas RC, Gill DB, Kemper C, Liszewski MK, Atkinson JP. 2004. CD46: expanding beyond complement regulation. Trends Immunol. 25: 496-503. http://dx.doi.org/10.1016/j.it.2004.07.004.
67. Cardoso AI, Gerlier D, Wild TF, Rabourdin-Combe C. 1996. The ectodomain of measles virus envelope glycoprotein does not gain access to the cytosol and MHC class I presentation pathway following virus-cell fusion. J. Gen. Virol. 77:2695-2699. http://dx.doi.org/10.1099/0022-1317-77-11-2695.
68. Levy S, Shoham T. 2005. The tetraspanin web modulates immunesignalling complexes. Nat. Rev. Immunol. 5:136-148. http://dx.doi.org /10.1038/nri1548.
69. Pols MS, Klumperman J. 2009. Trafficking and function of the tetraspanin CD63. Exp. Cell Res. 315:1584-1592. http://dx.doi.org/10.1016/j.yexcr.2008.09.020.
70. Engering A, Pieters J. 2001. Association of distinct tetraspanins with MHCclass II molecules at different subcellular locations in human immature dendritic cells. Int. Immunol. 13:127-134. http://dx.doi.org/10.1093 /intimm/13.2.127.
71. Soboll Hussey G, Hussey SB, Wagner B, Horohov DW, Van de Walle GR, Osterrieder N, Goehring LS, Rao S, Lunn DP. 2011. Evaluation of immune responses following infection of ponies with an EHV-1 ORF1/2 deletion mutant. Vet. Res. 42:23. http://dx.doi.org/10.1186/1297-9716-42-23.
72. Thomas M, Wills M, Lehner PJ. 2008. Natural killer cell evasion by an E3 ubiquitin ligase from Kaposi' s sarcoma-associated herpesvirus. Biochem. Soc. Trans. 36:459-463. http://dx.doi.org/10.1042/BST0360459.
73. Nathan JA, Lehner PJ. 2009. The trafficking and regulation of membrane receptors by the RING-CH ubiquitin E3 ligases. Exp. Cell Res. 315:1593-1600 http://dx.doi.org/10.1016/j.yexcr.2008.10.026.